To view or add a comment, sign in I appreciated the opportunity to be interviewed by Nick Paul Taylor for this BioSpace article discussing the FDAs recently published draft guidance, General Considerations for the Use of New Approach Methodologies in Drug Development. Historically, drug developers have often included in vitro NAM assay reports in regulatory submissions with limited explanatory context, resulting in minimal impact on the regulators safety assessment
Acharya, G., Wang, W., Vavilala, D
For best results, take Flatter Me Fiber with food and continue using Flatter Me with a different meal(s), such as one that may cause bloating
And it is far more common than most people realize
It is thought to work by lowering blood glucose by inducing insulin secretion through incretin action and reducing glucagon secretion
GLP-1RAs in patients with psoriasis